Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A Rosenkranz
Stimulatory Effects of the Multi-Kinase Inhibitor Sorafenib on Human Bladder Cancer Cells
British Journal of Pharmacology
Pharmacology
Related publications
Interleukin-27 Augments the Inhibitory Effects of Sorafenib on Bladder Cancer Cells
Brazilian Journal of Medical and Biological Research
Immunology
Cell Biology
Pharmacology
Biochemistry
Biophysics
Neuroscience
Medicine
Toxicology
Physiology
Pharmaceutics
Kinase Inhibitor Sorafenib Modulates Immunosuppressive Cell Populations in a Murine Liver Cancer Model
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
A Novel Combination Therapy Approach for the Treatment of Acute Myeloid Leukemia: The Multi-Kinase Inhibitor Sorafenib and the HDM2 Inhibitor Nutlin-3
Haematologica
Hematology
Corrigendum: Enhanced Cytotoxic Effects of Combined Valproic Acid and the Aurora Kinase Inhibitor VE465 on Gynecologic Cancer Cells
Frontiers in Oncology
Cancer Research
Oncology
Effects of Hyperthermia on Bladder Cancer
BMJ
The Impact of Sphingosine Kinase Inhibitor-Loaded Nanoparticles on Bioelectrical and Biomechanical Properties of Cancer Cells
Lab on a Chip - Miniaturisation for Chemistry and Biology
Biochemistry
Nanoscience
Bioengineering
Nanotechnology
Chemistry
Biomedical Engineering
Lapatinib, a Dual Inhibitor of ErbB-1/-2 Receptors, Enhances Effects of Combination Chemotherapy in Bladder Cancer Cells
International Journal of Oncology
Cancer Research
Oncology
Sorafenib N-Oxide Is an Inhibitor of Human Hepatic CYP3A4
AAPS Journal
Pharmaceutical Science
The Cyclin-Dependent Kinase Inhibitor Flavopiridol (Alvocidib) Inhibits Metastasis of Human Osteosarcoma Cells
Oncotarget
Oncology